Andreas Totzeck
Overview
Explore the profile of Andreas Totzeck including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
501
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Huntemann N, Gerischer L, Herdick M, Nelke C, Stascheit F, Hoffmann S, et al.
J Neurol Neurosurg Psychiatry
. 2025 Jan;
PMID: 39798960
Background: Myasthenia gravis (MG) is an autoimmune disorder affecting neuromuscular junctions, leading to fluctuating muscle weakness. While many patients respond well to standard immunosuppression, a substantial subgroup faces ongoing disease...
2.
Goerttler T, Dorner M, van der Linden C, Kienitz R, Petrik S, Blechinger S, et al.
Neurol Res Pract
. 2024 Oct;
6(1):52.
PMID: 39472968
Background: Intragastric botulinum neurotoxin injections (IBNI) are offered off-label in the private medical sector in a few European countries as a safe and effective weight-loss measure. In February and March...
3.
Mrochen A, Alhaj Omar O, Pelz J, Michalski D, Neugebauer H, Lehrieder D, et al.
Eur Stroke J
. 2024 Oct;
:23969873241289360.
PMID: 39397354
Introduction: Neurocritical care patients with neurovascular disease often face poor long-term outcomes, highlighting the pivotal role of evidence-based interventions. Although International Guidelines emphasize managing basic physiological parameters like temperature, blood...
4.
Paul N, Grunow J, Rosenthal M, Spies C, Page V, Hanison J, et al.
Neurocrit Care
. 2023 Sep;
40(3):898-908.
PMID: 37697129
Background: The objective of this study was to analyze the impact of a structured educational intervention on the implementation of guideline-recommended pain, agitation, and delirium (PAD) assessment. Methods: This was...
5.
Verhasselt H, Ramakrishnan E, Schlag M, Marchesi J, Buer J, Kleinschnitz C, et al.
J Fungi (Basel)
. 2023 May;
9(5).
PMID: 37233280
An altered gut microbiota is a possible contributing pathogenic factor in myasthenia gravis (MG), an autoimmune neuromuscular disease. However, the significance of the fungal microbiome is an understudied and neglected...
6.
Totzeck A, Jahn M, Stolte B, Thimm A, Kleinschnitz C, Hagenacker T
J Clin Med
. 2022 Aug;
11(15).
PMID: 35955999
Neuromuscular junction disorders (NJDs) are a heterogeneous group of diseases including myasthenia gravis (MG). In some cases, patients are present with myasthenic symptoms without evidence of autoimmune antibodies, making diagnosis...
7.
Nelke C, Stascheit F, Eckert C, Pawlitzki M, Schroeter C, Huntemann N, et al.
J Neuroinflammation
. 2022 Apr;
19(1):89.
PMID: 35413850
Background: Myasthenic crisis (MC) and disease exacerbation in myasthenia gravis (MG) are associated with significant lethality and continue to impose a high disease burden on affected patients. Therefore, we sought...
8.
Volk S, Pfirrmann M, Koedel U, Pfister H, Lang T, Scheibe F, et al.
J Neurol
. 2022 Mar;
269(7):3389-3399.
PMID: 35316388
Background And Objectives: In 2020, a wide range of hygiene measures was implemented to mitigate infections caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In consequence, pulmonary infections...
9.
Nelke C, Schroeter C, Stascheit F, Pawlitzki M, Regner-Nelke L, Huntemann N, et al.
J Neurol Neurosurg Psychiatry
. 2022 Mar;
93(5):548-554.
PMID: 35246490
Objective: Myasthenia gravis (MG) is the most common autoimmune disorder affecting the neuromuscular junction. However, evidence shaping treatment decisions, particularly for treatment-refractory cases, is sparse. Both rituximab and eculizumab may...
10.
Li Y, van Landeghem N, Demircioglu A, Kohrmann M, Kellner E, Milles L, et al.
Clin Neuroradiol
. 2022 Mar;
32(3):839-847.
PMID: 35244728
Purpose: We aimed to investigate treatment effect of endovascular thrombectomy (EVT) on the change of National Institutes of Health Stroke Scale (NIHSS) scores in acute ischemic stroke (AIS) patients with...